Inventor · disambiguated record
Christophe Demaison
Also filed as: DEMAISON CHRISTOPHE
3 granted patents·8 pending applications·3 citations·filing 2002–2024
56Inventor score
Top patents by PatentIndex Score
11 records- 0189US12017979B2MoleculesEna Respiratory Pty Ltd·Filed 2023·Granted Jun 25, 2024·2 cites·4 claims
- 0276US12195557B2Optimised compoundsAxelia Oncology Pty Ltd·Filed 2018·Granted Jan 14, 2025·1 cites·5 claims
- 0373US2025066416A1Optimised compoundsAxelia Oncology Pty Ltd·Filed 2024·Application pending·0 cites
- 0455US2022388950A1Novel moleculesAxelia Oncology Pty Ltd·Filed 2020·Application pending·0 cites
- 0543US7947469B2Modulation of HIV infectionGENDAQ LTD·Filed 2002·Granted May 24, 2011·0 cites·2 claims
- 0641US2004039175A1Modulation of viral gene expression by engineered zinc finger proteinsFiled 2002·Application pending·0 cites
- 0741US2023226004A1Treatment of coronavirusAxelia Oncology Pty Ltd·Filed 2021·Application pending·0 cites
- 0840US2022347146A1Cancer treatmentAxelia Oncology Pty Ltd·Filed 2020·Application pending·0 cites
- 0940US2023043518A1Cancer immunotherapyAxelia Oncology Pty Ltd·Filed 2020·Application pending·0 cites
- 1038US2021177795A1Administering compoundsEna Therapeutics Pty Ltd·Filed 2018·Application pending·0 cites
- 1137US2020147028A1Treatment of respiratory infection with a tlr2 agonistEna Therapeutics Pty Ltd·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christophe Demaison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →